About
Dr. George A. Scangos has served on the Agilent board since January 2011, where he chairs the Compensation Committee and serves on the Nominating/Corporate Governance Committee. He retired as Chief Executive Officer of Vir Biotechnology in April 2023 and previously served as CEO of Biogen Inc. (2010-2017), President and CEO of Exelixis, Inc. (1996-2010), and President of Bayer Biotechnology (1993-1996). He is a co-founder and Chairperson of Rezo Therapeutics and has served on the board of Voyager Therapeutics, Inc. since May 2023.
Roles
Agilent Technologies, Inc.
Director (Chair, Compensation Committee) · Current role
January 2011–present
Vir Biotechnology, Inc.
Chief Executive Officer · Retired April 2023; also a director January 2017 - May 2025
—
Biogen Inc.
Chief Executive Officer and director
July 2010 - January 2017
Exelixis, Inc.
President and Chief Executive Officer
1996 - July 2010
Bayer Biotechnology
President
1993 - 1996
Johns Hopkins University
Professor of Biology · Currently Adjunct Professor of Biology
1981 -
External Roles
Voyager Therapeutics, Inc.
Director
May 2023 - present
Rezo Therapeutics, Inc.
Co-founder and Chairperson of the Board
May 2023 - present
Director Compensation
FY 2025
Compensation Committee Chair retainer
$20,000
Also at Agilent Technologies, Inc.